Final ID: TP314
Souza Freire Camila Veronica, Gupta Sumit, Aghayev Ayaz, Steigner Michael, Mccarthy Cian, Lu Michael, Hedgire Sandeep, Di Carli Marcelo, Ghoshhajra Brian, Blankstein Ron, Huck Daniel, Berman Adam, Besser Stephanie, Shiyovich Arthur, Weber Brittany, Cardoso Rhanderson, Biery David, Miao Joanne, Hainer Jon
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.